Animal Model Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Animal Model market is segmented By Animal Type (Mice, Birds, Fish, Cattles, Others), Technology, Application and Geography.

Market Snapshot

Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The animal model market is expected to register a CAGR of 8.6% over the forecast period. The key contributors in the market growth are increasing number of clinical trials and increasing spending on these studies. As per the data of Europeans Medicine Agency, currently (2020) there are 37,293 clinical trials registered in Europe. Furthermore, according to the World Health Organization, in 2019, the number of registered trials were around 92% in South East Asia and around 66% in the Eastern Mediterranean region. Animal models are considered as a fundamental tool in clinical research studies for predicting the data for humans. It helps in determining the pharmacodynamic and pharmacokinectics of the drugs. Furthermore, according to the European Federation of Pharmaceutical Industries and Associations, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD.

Scope of the Report

Various species of animals are used in clinical studies as it has functional resemblance to the human body. Animal Model Market is segmented By Product Type, By Technology, By Application and Geography.

By Animal Type
Mice
Birds
Fish
Cattles
Others
By Technology
CRISPR
Embryonic Stem Cell Injection
Nuclear Transfer
Others
By Application
Oncology
Cardiovascular
Neurology
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Mice Segment is Expected to Exhibhit a Significant Market Growth in the Animal Model Market

The mice model segment is expected to show a significant growth in the market, primarily due to the increase in R&D activities in pharmaceutical industries. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD.

Mice and humans have around 95% of similarity in DNA and therefore it has wide range of applications such as in oncology studies, immunology and inflammation studies, central nervous system studies (anxiety and other disorders), cardiovascular studies, and diabetes studies. Thus, mice models are expected to have a larger demand in the market.

PAT Market Trend.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Animal Model market owing to increasing investments and number of clinical trials. According to the clinical trials.gov, in 2019, around 293,321 studies were registered during the start of the year and around 32,523 at the end of year. Moreover, according to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies were around 79.6 billion USD in the United States. Thus, the increasing number of clinical trials and heavy investments into these studies is expected to boost up the demand of pharmaceutical analytical testing market growth in the North America Region.

Animal Model Market - Growth Rate by Region

Competitive Landscape

Key players that are expected to be dominant in Animal Model market are Charles River, Envigo, Genoway, Harbour Biomed, Janvier Labs, Taconic Biosciences, The Jackson Laboratory, Trans Genic Inc., Hera Biolabs and Biocytogen

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Personalized Medicine

      2. 4.2.2 Increasing Number of Research & Development Activities

    3. 4.3 Market Restraints

      1. 4.3.1 Regulation for Ethical Use of Animals

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Animal Type

      1. 5.1.1 Mice

      2. 5.1.2 Birds

      3. 5.1.3 Fish

      4. 5.1.4 Cattles

      5. 5.1.5 Others

    2. 5.2 By Technology

      1. 5.2.1 CRISPR

      2. 5.2.2 Embryonic Stem Cell Injection

      3. 5.2.3 Nuclear Transfer

      4. 5.2.4 Others

    3. 5.3 By Application

      1. 5.3.1 Oncology

      2. 5.3.2 Cardiovascular

      3. 5.3.3 Neurology

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Biocytogen

      2. 6.1.2 Charles River

      3. 6.1.3 Envigo

      4. 6.1.4 Genoway

      5. 6.1.5 Harbour Biomed

      6. 6.1.6 Hera Biolabs

      7. 6.1.7 Janvier Labs

      8. 6.1.8 Taconic Biosciences

      9. 6.1.9 The Jackson Laboratory

      10. 6.1.10 Trans Genic Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Animal Model Market market is studied from 2018 - 2026.

The Animal Model Market is growing at a CAGR of 8.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Charles River, Envigo, Genoway, Harbour Biomed, Janvier Labs are the major companies operating in Animal Model Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!